The cardinal role of the phospholipase A 2/cyclooxygenase-2/ prostaglandin e synthase/prostaglandin E 2 (PCPP) axis in inflammostasis

Inflammation Research

Volumn 60, Issue 12, 2011, Pages 1083-1092

  Mancini, A D ^a,b   Di Battista, J A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

COX 1 2; Inflammatory mediators; Models of joint inflammation; Prostaglandins; RA

Indexed keywords

CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPASE A2; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

AUTOREGULATION; BIOSYNTHESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MODULATION; MOLECULAR MECHANICS; POSITIVE FEEDBACK; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; PHOSPHOLIPASES A2; SIGNAL TRANSDUCTION;

EID: 84855245938     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0385-7     Document Type: Review

References (106)

1. GL Bannenberg N Chiang A Ariel M Arita E Tjonahen KH Gotlinger S Hong CN Serhan 2005 Molecular circuits of resolution: formation and actions of resolvins and protectins J Immunol 174 4345 4355 15778399 1:CAS:528:DC%2BD2MXisVCht7o%3D (Pubitemid 40396017)
2. GB Ryan G Majno 1977 Acute inflammation Am J Pathol 86 185 274 1:CAS:528:DyaE2sXmvFCksA%3D%3D
3. DE Doherty GP Downey GS Worthen C Haslett PM Henson 1988 Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils Lab Invest 59 200 213 3404972 1:STN:280:DyaL1czgtFGguw%3D%3D
4. G Kaplanski V Marin F Montero-Julian A Mantovani C Farnarier 2003 IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation Trends Immunol 24 24 29
5. KS Janardhan SK Sandhu B Singh 2006 Neutrophil depletion inhibits early and late monocyte/macrophage increase in lung inflammation Front Biosci 11 1569 1576 16368537 1:CAS:528:DC%2BD28XislSns78%3D 10.2741/1904 (Pubitemid 43253442)
6. J Ma T Chen J Mandelin A Ceponis NE Miller M Hukkanen GF Ma YT Konttinen 2003 Regulation of macrophage activation Cell Mol Life Sci 60 2334 2346 14625680 1:CAS:528:DC%2BD2cXjvFelsro%3D 10.1007/s00018-003-3020-0 (Pubitemid 37487255)
7. DM Underhill M Bassetti A Rudensky A Aderem 1999 Dynamic interactions of macrophages with T cells during antigen presentation J Exp Med 190 1909 1914 10601366 1:CAS:528:DC%2BD3cXitlGj 10.1084/jem.190.12.1909 (Pubitemid 30013857)
8. CN Serhan 2005 Novel omega-3-derived local mediators in anti-inflammation and resolution Pharmacol Ther 105 7 21 15626453 1:CAS:528:DC%2BD2MXjsVGh 10.1016/j.pharmthera.2004.09.002 (Pubitemid 40044765)
9. T Krakauer 2004 Molecular therapeutic targets in inflammation: cyclooxygenase and NF -kappaB Curr Drug Targets Inflamm Allergy 3 317 324 15379601 1:CAS:528:DC%2BD2cXmvVemur0%3D 10.2174/1568010043343714 (Pubitemid 39206661)
10. JA Di Battista QW He B Zhai A Mancini 2009 Modulation of the inflammatory and catabolic response by prostaglandin E2 (PGE2) is partially dependent on the induction of dual specificity phosphatase 1 (DUSP-1) in vitro and in vivo Inflamm Res 58 Suppl 2 S97
11. WH Faour N Alaaeddine A Mancini QW He D Jovanovic JA Di Battista 2005 Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor-α gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts J Biol Chem 280 9536 9546 15640148 1:CAS:528:DC%2BD2MXitVChs7w%3D 10.1074/jbc.M414067200 (Pubitemid 40409649)
12. F Giuliano TD Warner 2002 Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems J Pharmacol Exp Ther 303 1001 1006 12438520 1:CAS:528:DC%2BD38XptlamtLw%3D 10.1124/jpet.102.041244 (Pubitemid 35424382)
13. W He JP Pelletier J Martel-Pelletier S Laufer JA Di Battista 2002 Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines J Rheumatol 29 546 553 11908571 1:CAS:528:DC%2BD38XisVWltrk%3D (Pubitemid 34202826)
14. M Murakami K Nakashima D Kamei S Masuda Y Ishikawa T Ishii Y Ohmiya K Watanabe I Kudo 2003 Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2 J Biol Chem 278 37937 37947 12835322 1:CAS:528:DC%2BD3sXnsV2ltbo%3D 10.1074/jbc.M305108200 (Pubitemid 37175324)
15. MM Chan AR Moore 2010 Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production J Immunol 184 6418 6426 20435922 1:CAS:528:DC%2BC3cXmtFyqtb4%3D 10.4049/jimmunol.0903816
16. P Davies PJ Bailey MM Goldenberg AW Ford-Hutchinson 1984 The role of arachidonic acid oxygenation products in pain and inflammation Annu Rev Immunol 2 335 357 6100476 1:CAS:528:DyaL2cXkslShtr8%3D 10.1146/annurev.iy.02.040184. 002003
17. JR Vane 1971 Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs Nat New Biol 231 232 235 5284360 1:CAS:528:DyaE3MXltVyjur4%3D
18. J Shi J Johansson NS Woodling Q Wang TJ Montine K Andreasson 2010 The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity J Immunol 184 7207 7218 20483760 1:CAS:528: DC%2BC3cXmvFejtrc%3D 10.4049/jimmunol.0903487
19. BD Levy CB Clish B Schmidt K Gronert CN Serhan 2001 Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 612 619 11429545 1:CAS:528:DC%2BD3MXltFSlsL4%3D 10.1038/89759 (Pubitemid 32677628)
20. AL Groeger C Cipollina MP Cole SR Woodcock G Bonacci TK Rudolph V Rudolph BA Freeman FJ Schopfer 2010 Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids Nat Chem Biol 6 433 441 20436486 1:CAS:528:DC%2BC3cXlsVyitLc%3D 10.1038/nchembio.367
21. DW Gilroy PR Colville-Nash D Willis J Chivers MJ Paul-Clark DA Willoughby 1999 Inducible cyclooxygenase may have anti-inflammatory properties Nat Med 5 698 701 10371510 1:CAS:528:DyaK1MXjs1Klt7Y%3D 10.1038/9550 (Pubitemid 29289435)
22. JL Cash GE White DR Greaves 2009 Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation Methods Enzymol 461 379 396 19480928 1:CAS:528:DC%2BD1MXptlynsbo%3D 10.1016/S0076-6879(09)05417- 2
23. R Rajakariar M Hilliard T Lawrence S Trivedi P Colville-Nash G Bellingan D Fitzgerald MM Yaqoob DW Gilroy 2007 Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2 Proc Natl Acad Sci USA 104 20979 20984 18077391 1:CAS:528:DC%2BD1cXksFSltg%3D%3D 10.1073/pnas.0707394104
24. A Rossi P Kapahi G Natoli T Takahashi Y Chen M Karin MG Santoro 2000 Antiinflammatory cyclopentenone prostaglandins are direct inhibitors of Ikappa B kinase Nature 403 103 108 10638762 1:CAS:528:DC%2BD3cXlvVWjsw%3D%3D 10.1038/47520 (Pubitemid 30038530)
25. DS Straus G Pascual M Li JS Welch M Ricote CH Hsiang LL Sengchanthalangsy G Ghosh CK Glass 2000 15-deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc Natl Acad Sci USA 97 4844 4849 10781090 1:CAS:528:DC%2BD3cXivFKjurY%3D 10.1073/pnas.97.9.4844 (Pubitemid 30238645)
26. CL Bell-Parikh T Ide JA Lawson P McNamara M Reilly GA FitzGerald 2003 Biosynthesis of 15-deoxy-delta12, 14-PGJ2 and the ligation of PPAR gamma J Clin Invest 112 945 955 12975479 1:CAS:528:DC%2BD3sXnsVGntLg%3D
27. H Martin 2009 Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components Mutat Res 669 1 7 19563816 1:CAS:528:DC%2BD1MXhtFGls7rM 10.1016/j.mrfmmm.2009.06.009
28. MA Bouhlel B Derudas E Rigamonti R Dièvart J Brozek S Haulon C Zawadzki B Jude G Torpier N Marx B Staels G Chinetti-Gbaguidi 2007 PPAR-gamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab 6 137 143 17681149 1:CAS:528: DC%2BD2sXpsFelsrg%3D 10.1016/j.cmet.2007.06.010 (Pubitemid 47189091)
29. JI Odegaard RR Ricardo-Gonzalez MH Goforth CR Morel V Subramanian L Mukundan A Red Eagle D Vats F Brombacher AW Ferrante Jr A Chawla 2007 Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 1116 1120 17515919 1:CAS:528:DC%2BD2sXmvFKmu78%3D 10.1038/nature05894 (Pubitemid 47014427)
30. R Hontecillas J Bassaganya-Riera 2007 Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis J Immunol 178 2940 2949 17312139 1:CAS:528:DC%2BD2sXhvFSisb8%3D (Pubitemid 46333173)
31. M Ricote AC Li TM Willson CJ Kelly CK Glass 1998 The peroxisome proliferator activated receptor-gamma is a negative regulator of macrophage activation Nature 391 79 82 9422508 1:CAS:528:DyaK1cXktVShtQ%3D%3D 10.1038/34178 (Pubitemid 28079218)
32. T Kalajdzic WH Faour QW He J Martel-Pelletier JP Pelletier JA Di Battista 2002 Nimesulide, a preferential cyclooxygenase-2 inhibitor, suppresses peroxisomeproliferator activated receptor induction of cyclooxygenase-2 gene expression in human synovial fibroblasts: evidence for receptor antagonism Arthritis Rheum 46 494 506 11840453 1:CAS:528:DC%2BD38XhvF2qsrs%3D 10.1002/art.10055 (Pubitemid 34136588)
33. JU Scher MH Pillinger 2005 15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol 114 100 109 15639643 1:CAS:528:DC%2BD2MXhvFyrsA%3D%3D 10.1016/j.clim.2004.09.008 (Pubitemid 40082375)
34. B Zhai H Yang A Mancini Q He J Antoniou JA Di Battista 2010 Leukotriene B4 BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway J Biol Chem 285 23568 23580 20489206 1:CAS:528:DC%2BC3cXptFOrtbg%3D 10.1074/jbc.M110.107623
35. CN Serhan N Chiang TE Van Dyke 2008 Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 349 361 18437155 1:CAS:528:DC%2BD1cXltFejsbw%3D 10.1038/nri2294 (Pubitemid 351595216)
36. C Brenneis O Coste K Altenrath C Angioni H Schmidt CD Schuh DD Zhang M Henke A Weigert B Brüne B Rubin R Nusing K Scholich G Geisslinger 2011 Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation J Biol Chem 286 2331 2342 21075851 1:CAS:528: DC%2BC3MXlsFWitg%3D%3D 10.1074/jbc.M110.157362
37. H Yin L Cheng R Langenbach C Ju 2007 Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury Hepatology 45 159 169 17187424 1:CAS:528:DC%2BD2sXht1artr0%3D 10.1002/hep.21493 (Pubitemid 46144375)
38. GM Gauvreau RM Watson PM O'Byrne 1999 Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation Am J Respir Crit Care Med 159 31 36 9872814 1:STN:280:DyaK1M%2FptFyhtQ%3D%3D (Pubitemid 29036499)
39. SK Huang M Peters-Golden 2008 Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? Chest 133 1442 1450 18574287 1:CAS:528:DC%2BD1cXovFektL4%3D 10.1378/chest.08-0306 (Pubitemid 351899641)
40. A Herrerias R Torres M Serra A Marco L Pujols C Picado F de Mora 2009 Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2 J Inflamm (Lond) 6 30 10.1186/1476-9255-6-30 1:CAS:528:DC%2BD1MXhtl2ht7fM
41. CM Hogaboam EY Bissonnette BC Chin AD Befus JL Wallace 1993 Prostaglandins inhibit inflammatory mediator release from rat mast cells Gastroenterology 104 122 129 7678236 1:CAS:528:DyaK3sXhs1WlsLs%3D (Pubitemid 23040014)
42. PH Hart GA Whitty DS Piccoli JA Hamilton 1989 Control by IFN-g and PGE2 of TNFa and IL-1 production by human monocytes Immunology 66 376 383 2495247 1:CAS:528:DyaL1MXhvFSrsLw%3D (Pubitemid 19092827)
43. K Takayama G García-Cardena GK Sukhova J Comander MA Gimbrone Jr P Libby 2002 Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor J Biol Chem 277 44147 44154 12215436 1:CAS:528:DC%2BD38Xos1aksbc%3D 10.1074/jbc.M204810200 (Pubitemid 36157844)
44. Z Szekanecz J Kim AE Koch 2003 Chemokines and chemokine receptors in rheumatoid arthritis Semin Immunol 15 15 21 12495637 1:CAS:528: DC%2BD38XpsFyhtro%3D 10.1016/S1044-5323(02)00124-0 (Pubitemid 36092175)
45. R Largo I Díez-Ortego O Sanchez-Pernaute MJ López-Armada MA Alvarez-Soria J Egido G Herrero-Beaumont 2004 EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1b in synovial fibroblasts Ann Rheum Dis 63 1197 1204 15361371 1:CAS:528: DC%2BD2cXovFOmsro%3D 10.1136/ard.2003.011163 (Pubitemid 39273493)
46. H Jing E Vassiliou D Ganea 2003 Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells J Leukoc Biol 74 868 879 12960284 1:CAS:528:DC%2BD3sXpt1CrtLY%3D 10.1189/jlb.0303116 (Pubitemid 38040363)
47. E Vassiliou H Jing D Ganea 2003 Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells Cell Immunol 223 120 132 14527510 1:CAS:528:DC%2BD3sXns1Krtr8%3D 10.1016/S0008-8749(03)00158-8 (Pubitemid 37188379)
48. WA Wertheim SL Kunkel TJ Standiford MD Burdick FS Becker CA Wilke AR Gilbert RM Strieter 1993 Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4 J Immunol 151 2166 2175 8345201 1:CAS:528:DyaK3sXmt1eqtL8%3D (Pubitemid 23235690)
49. M Pouliot ME Fiset M Massé PH Naccache P Borgeat 2002 Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation J Immunol 169 5279 5286 12391247 (Pubitemid 35217200)
50. M St-Onge N Flamand J Biarc S Picard L Bouchard AA Dussault C Laflamme MJ James GE Caughey LG Cleland P Borgeat M Pouliot 2007 Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils Biochem Biophys Acta 1771 1235 1245 17643350 1:CAS:528: DC%2BD2sXhtVOgsrzL (Pubitemid 47411628)
51. S Persson A Mikulowska S Narula A O'Garra R Holmdahl 1996 Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats Scand J Immunol 44 607 614 8972743 1:CAS:528:DyaK2sXisVWrsA%3D%3D 10.1046/j.1365-3083.1996.d01-355.x (Pubitemid 26400375)
52. LA Joosten E Lubberts P Durez MM Helsen MJ Jacobs M Goldman WB van den Berg 1997 Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction Arthritis Rheum 40 249 260 9041936 1:CAS:528: DyaK2sXhvVers7Y%3D 10.1002/art.1780400209 (Pubitemid 27114088)
53. S Cuzzocrea E Mazzon L Dugo I Serraino D Britti M De Maio AP Caputi 2001 Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis Eur Cytokine Network 12 568 580 1:CAS:528: DC%2BD38Xht1SksbY%3D (Pubitemid 34062143)
54. A Finnegan CD Kaplan Y Cao H Eibel TT Glant J Zhang 2003 Collagen-induced arthritis is exacerbated in IL-10-deficient mice Arthritis Res Ther 5 R18 R24 12716449 1:CAS:528:DC%2BD38XpsFWltLw%3D 10.1186/ar601
55. K Evans S Fox 2007 Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus BMC Cell Biol 8 4 17239241 10.1186/1471-2121-8-4 1:CAS:528:DC%2BD2sXhvFCgurg%3D (Pubitemid 46210959)
56. JCW Edwards AD Sedgwick DA Willoughby 1981 The formation of a structure with features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system J Pathol 134 147 156 7019400 1:STN:280: DyaL3M3ktFyjsA%3D%3D 10.1002/path.1711340205 (Pubitemid 11065839)
57. SM Abraham T Lawrence A Kleiman P Warden M Medghalchi J Tuckermann J Saklatvala AR Clark 2006 Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase J Exp Med 203 1883 1889 16880258 1:CAS:528:DC%2BD28XotleisL4%3D 10.1084/jem.20060336 (Pubitemid 44188463)
58. S Narumiya GA FitzGerald 2001 Genetic and pharmacological analysis of prostanoid receptor function J Clin Invest 108 25 30 11435452 1:CAS:528:DC%2BD3MXkvVarsrY%3D (Pubitemid 32634917)
59. RJ Soberman P Christmas 2003 The organization and consequences of eicosanoid signaling J Clin Invest 111 1107 1113 12697726 1:CAS:528: DC%2BD3sXjtFCrsr8%3D (Pubitemid 36519924)
60. Y Sugimoto S Naruyima 2007 Prostaglandin E receptors J Biol Chem 282 11613 11617 17329241 1:CAS:528:DC%2BD2sXktFemtbs%3D 10.1074/jbc.R600038200 (Pubitemid 47100657)
61. Gerarduzzi C. PhD Thesis, Department of Experimental Medicine, McGill University, 2009. Characterizing the activating and attenuating signal scaffolding units of the PGE2-EP receptor system in normal and arthritic human synovial fibroblasts (John A and Di Battista, Supervisor).
62. W Faour HY He, et al. 2001 Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts J Biol Chem 276 31720 31731 11423555 1:CAS:528:DC%2BD3MXms1Sms74%3D 10.1074/jbc.M104036200
63. PF Gomez MH Pillinger M Attur N Marjanovic M Dave J Park CO Bingham 3rd H Al-Mussawir SB Abramson 2005 Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts J Immunol 175 6924 6930 16272352 1:CAS:528:DC%2BD2MXhtF2ju7nL (Pubitemid 41598938)
64. SY Min WU Kim ML Cho SY Hwang SH Park CS Cho JM Kim HY Kim 2002 Prostaglandin E2 suppresses nuclear factor-kappaB mediated interleukin 15 production in rheumatoid synoviocytes J Rheumatol 29 1366 1376 12136890 1:CAS:528:DC%2BD38XmtVGjtL0%3D
65. E Shaulian M Karin 2002 AP-1 as a regulator of cell life and death Nat Cell Biol 4 E131 E136 11988758 1:CAS:528:DC%2BD38Xjt1Kgsbg%3D 10.1038/ncb0502-e131 (Pubitemid 34521026)
66. RG Ott O Simma K Kollmann E Weisz EM Zebedin M Schorpp-Kistner G Heller S Zöchbauer EF Wagner M Freissmuth V Sexl 2007 JunB is a gatekeeper for B lymphoid leukemia Oncogene 26 4863 4871 17297445 1:CAS:528:DC%2BD2sXnvFarur4%3D 10.1038/sj.onc.1210285 (Pubitemid 47093176)
67. E Passegue EF Wagner 2000 JunB suppresses cell proliferation by transcriptional activation of p16 (INK4a) expression EMBO J 19 2969 2979 10856241 1:CAS:528:DC%2BD3cXmtFCqs7w%3D 10.1093/emboj/19.12.2969 (Pubitemid 30386768)
68. H Hasturk A Kantarci E Goguet-Surmenian A Blackwood C Andry CN Serhan TE Van Dyke 2007 Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo J Immunol 179 7021 7029 17982093 1:CAS:528:DC%2BD2sXht1Crs7rL
69. C Godson S Mitchell K Harvey NA Petasis N Hogg HR Brady 2000 Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages J Immunol 164 1663 1667 10657608 1:CAS:528:DC%2BD3cXhtlymsbo%3D (Pubitemid 30108713)
70. JF Maddox M Hachicha T Takano NA Petasis VV Fokin CN Serhan 1997 Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor J Biol Chem 272 6972 6978 9054386 1:CAS:528:DyaK2sXhvFKjtr0%3D 10.1074/jbc.272.49.30993 (Pubitemid 27527544)
71. JF Maddox CN Serhan 1996 Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction J Exp Med 183 137 146 8551217 1:CAS:528:DyaK28XjsVCgsw%3D%3D 10.1084/jem.183.1.137 (Pubitemid 26028753)
72. A Ariel G Fredman YP Sun A Kantarci TE Van Dyke AD Luster CN Serhan 2006 Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression Nat Immunol 7 1209 1216 17013391 1:CAS:528:DC%2BD28XhtV2gsrbO 10.1038/ni1392 (Pubitemid 44594317)
73. JM Schwab N Chiang M Arita CN Serhan 2007 Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 869 874 17568749 1:CAS:528:DC%2BD2sXms1Wjtrc%3D 10.1038/nature05877 (Pubitemid 46920139)
74. J Shen E Herderick JF Cornhill E Zsigmond HS Kim H Kühn NV Guevara L Chan 1996 Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development J Clin Invest 98 2201 2208 8941635 1:CAS:528:DyaK28XntVOhs7Y%3D 10.1172/JCI119029 (Pubitemid 26394192)
75. CN Serhan A Jain S Marleau C Clish A Kantarci B Behbehani SP Colgan GL Stahl A Merched NA Petasis L Chan TE Van Dyke 2003 Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators J Immunol 171 6856 6865 14662892 1:CAS:528:DC%2BD3sXpsV2rtbc%3D (Pubitemid 37532121)
76. CN Serhan JF Maddox NA Petasis I Akritopoulou-Zanze A Papayianni HR Brady SP Colgan JL Madara 1995 Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils Biochemistry 34 14609 14615 7578068 1:CAS:528:DyaK2MXoslGhsLk%3D 10.1021/bi00044a041 (Pubitemid 3000720)
77. CB Clish JA O'Brien K Gronert GL Stahl NA Petasis CN Serhan 1999 Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc Natl Acad Sci USA 96 8247 8252 10393980 1:CAS:528:DyaK1MXltVOrsbk%3D 10.1073/pnas.96.14.8247 (Pubitemid 29328440)
78. CB Clish BD Levy N Chiang HH Tai CN Serhan 2000 Oxidoreductases in lipoxin A4 metabolic inactivation J Biol Chem 275 25372 25380 10837478 1:CAS:528:DC%2BD3cXmtVehs78%3D 10.1074/jbc.M002863200
79. CN Serhan CB Clish J Brannon SP Colgan N Chiang K Gronert 2000 Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellular processing J Exp Med 192 1197 1204 11034610 1:CAS:528:DC%2BD3cXnsVaqsrc%3D 10.1084/jem.192.8.1197
80. CN Serhan S Hong K Gronert SP Colgan PR Devchand G Mirick RL Moussignac 2002 Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 1025 1037 12391014 1:CAS:528: DC%2BD38XotFGltLc%3D 10.1084/jem.20020760 (Pubitemid 35231761)
81. M Arita F Bianchini J Aliberti A Sher N Chiang S Hong R Yang NA Petasis CN Serhan 2005 Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J Exp Med 201 713 722 15753205 1:CAS:528:DC%2BD2MXitl2rt74%3D 10.1084/jem.20042031 (Pubitemid 40395117)
82. L József C Zouki NA Petasis CN Serhan JG Filep 2002 Lipoxin A4 and aspirintriggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes Proc Natl Acad Sci USA 99 13266 13271 12235371 10.1073/pnas.202296999 1:CAS:528: DC%2BD38XnvFGgs7w%3D
83. S Sodin-Semrl B Taddeo D Tseng J Varga S Fiore 2000 Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases J Immunol 164 2660 2666 10679106 1:CAS:528: DC%2BD3cXhsVKhtLw%3D (Pubitemid 30115498)
84. DA Dixon CD Kaplan TM McIntyre GA Zimmerman SM Prescott 2000 Posttranscriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region J Biol Chem 275 11750 11757 10766797 1:CAS:528:DC%2BD3cXisl2js78%3D 10.1074/jbc.275.16.11750 (Pubitemid 30237739)
85. A Mancini DV Jovanovic QW He JA Di Battista 2007 Site-specific proteolysis of cyclooxygenase-2: a putative step in inflammatory prostaglandin E(2) biosynthesis J Cell Biochem 101 425 441 17177291 1:CAS:528: DC%2BD2sXltFCrur4%3D 10.1002/jcb.21191 (Pubitemid 46698876)
86. AD Mancini JA Di Battista 2008 Tristetraprolin: a prostaglandin E2-responsive bifunctional regulator of cyclooxygenase-2 expression Osteoarthr Cartil 16 Suppl 4 S16 10.1016/S1063-4584(08)60053-9
87. WS Lai E Carballo JR Strum EA Kennington RS Phillips PJ Blackshear 1999 Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA Mol Cell Biol 19 4311 4323 10330172 1:CAS:528:DyaK1MXjt1yisrw%3D (Pubitemid 29242006)
88. A Raghavan RL Robison J McNabb CR Miller DA Williams PR Bohjanen 2001 HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities J Biol Chem 276 47958 47965 11602610 1:CAS:528:DC%2BD38XkvFKr 10.1074/jbc.M103797200
89. H Yu S Stasinopoulos P Leedman RL Medcalf 2003 Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin J Biol Chem 278 13912 13918 12578825 1:CAS:528:DC%2BD3sXjtVSitb8%3D 10.1074/jbc.M213027200 (Pubitemid 36799932)
90. G Sully JL Dean R Wait L Rawlinson T Santalucia J Saklatvala AR Clark 2004 Structural and functional dissection of a conserved destabilizing element of cyclooxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1) Biochem J 377 Pt 3 629 639 14594446 1:CAS:528:DC%2BD2cXls1GlsQ%3D%3D (Pubitemid 38221834)
91. CR Tchen M Brook J Saklatvala AR Clark 2004 The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself J Biol Chem 279 32393 32400 15187092 1:CAS:528:DC%2BD2cXmtVChsLc%3D 10.1074/jbc.M402059200 (Pubitemid 39014693)
92. K Linker A Pautz M Fechir T Hubrich J Greeve H Kleinert 2005 Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR Nucleic Acids Res 33 4813 4827 16126846 1:CAS:528:DC%2BD2MXpvFKjtLo%3D 10.1093/nar/gki797 (Pubitemid 41418881)
93. U Jalonen R Nieminen K Vuolteenaho H Kankaanranta E Moilanen 2006 Downregulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3 alpha synthesis in activated macrophages Mediators Inflamm 2006 40691 17392586 10.1155/MI/2006/40691 1:CAS:528: DC%2BD2sXjvFWltrk%3D (Pubitemid 46026543)
94. H Sandler G Stoecklin 2008 Control of mRNA decay by phosphorylation of tristetraprolin Biochem Soc Trans 36 491 496 18481987 1:CAS:528: DC%2BD1cXmtVKlt7Y%3D 10.1042/BST0360491 (Pubitemid 351839361)
95. I Tegeder E Niederberger E Israr H Gühring K Brune C Euchenhofer S Grösch G Geisslinger 2001 Inhibition of NF-kappaB and AP-1 activation by R- and S- flurbiprofen FASEB J 15 2 4 11099482 1:CAS:528:DC%2BD3MXht1Snsrg%3D 10.1096/fj.01-0390rev (Pubitemid 32927924)
96. JF Fries 1991 NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal J Rheumatol 28 6 10 1:STN:280:DyaK3M3ksFGitg%3D%3D
97. PM Brooks RO Day 1991 Nonsteroidal anti-inflammatory drugs-differences and similarities New Engl J Med 324 1716 1725 2034249 1:STN:280: DyaK3M3jvV2isQ%3D%3D 10.1056/NEJM199106133242407
98. R Matuk J Crawford MT Abreu SR Targan EA Vasiliauskas KA Papadakis 2004 The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease Inflamm Bowel Dis 10 352 356 15475742 10.1097/00054725-200407000-00005 (Pubitemid 39029177)
99. K Takeuchi S Smale P Premchand L Maiden R Sherwood B Thjodleifsson E Bjornsson I Bjarnason 2006 Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease Clin Gastroenterol Hepatol 4 196 202 16469680 1:CAS:528: DC%2BD28Xit1Gqu7c%3D 10.1016/S1542-3565(05)00980-8 (Pubitemid 43199690)
100. AD Cohen DY Bonneh H Reuveni DA Vardy L Naggan S Halevy 2005 Drug exposure and psoriasis vulgaris: case-control and case-crossover studies Acta Derm Venereol 85 299 303 16191849 1:CAS:528:DC%2BD2MXhtVWqtr3P 10.1080/00015550510032823 (Pubitemid 41113510)
101. H Katayama A Kawada 1981 Exacerbation of psoriasis induced by indomethacin J Dermatol 8 323 327 7028832 1:STN:280:DyaL38%2Fltlyhtg%3D%3D (Pubitemid 12235552)
102. XM Wang TX Wu YS Lee RA Dionne 2006 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors Clin Pharmacol Ther 79 303 315 16580899 1:CAS:528:DC%2BD28XjtFaiur8%3D 10.1016/j.clpt.2005.12.306
103. MJ Stables DW Gilroy 2011 Old and new generation lipid mediators in acute inflammation and resolution Prog Lipid Res 50 35 51 20655950 1:CAS:528:DC%2BC3cXhs1WktL7P 10.1016/j.plipres.2010.07.005
104. CN Serhan 2007 Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu Rev Immunol 25 101 137 17090225 1:CAS:528:DC%2BD2sXltlagu7w%3D 10.1146/annurev.immunol.25. 022106.141647 (Pubitemid 46697904)
105. Proceedings of the 9th World Congress on Inflammation, July 6-10 2009, Tokyo, Japan. Inflammation Res. 58(Suppl 2):S79-S279.
106. L Sun G Stoecklin S Van Way V Hinkovska-Galcheva RF Guo P Anderson TP Shanley 2007 Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA J Biol Chem 282 3766 3777 17170118 1:CAS:528: DC%2BD2sXht1Kqt7k%3D 10.1074/jbc.M607347200 (Pubitemid 47084478)